Lianhe Chemical Technology Co., Ltd.
联化科技
002250
Shenzhen Stock Exchange
Company Profile
1. Unique operating model The Company implements the key customer strategy. Based on core customer resources and customer-oriented, the Company continuously deepens the complementation of contract research and manufacturing services and marketing its own products to meet and guide customer needs. The effective complementation of contract manufacturing and marketing its own products drives a rapid development for the Company’s business. The contract research and manufacturing services are the company's main business model. It is cooperated with customers since the early research and development stage of the project, synchronously accesses the product supply chain system, and then provides manufacturing services for customers after the products are launched. The company's core customers occupy a great important position in the world's chemical and pharmaceutical fields. Once the partnership between the company and customer is established, the cooperation is stable and long-term. Marketing its own products as known as Self-Production and Self-Selling is a business model in which the company masters product technology, customer resources and sales channels by itself, and prices of product follow the market. The company utilizes several major technology categories and advantageous products independently mastered to lay out in the industry chain and consolidate the competitive advantages. After years of research and exploration in the field of chemistry, the company has accumulated rich experience in technical reserves, process development and has continuously improved its technical research and development capabilities and production control capabilities. While providing high-quality customized processing services for multinational giant clients, the company can continuously develop advanced serialized independent products according to changes in the international market. 2. Construction of intelligent platform for technological innovation Adhering to a technology driven development, the Company has established a multi-layer R&D platform, including three levels: the early-stage R&D platform, the mid-project R&D platform, and the technical transformation platform of each subsidiary. Through the efficient operation of the R&D platforms and continuous technological innovation, the company has expanded the core technology fields owned by the company and improved the market competitiveness of customer products and self-owned products. As of December 31, 2024, the Company has been granted 99 domestic invention patents and 61 utility model patents for each business segment, and owns one European invention patent. 3. Extensive chemical technology application capabilities For products that are mature in the market and those whose patents are about to expire, the R&D team ensures the cost advantage of the products through technological innovation and process optimization, provides customers with professional and systematic solutions with market competitiveness; for the market introduction period and new products to be launched soon, the R&D team and the core customer team cooperate to innovate in process research and development pilot scale up production design, and provide customers with a flexible and efficient one-stop service. Our Jiangkou Site, LianheAigen and Seal Sands Site have all passed FDA audits, and the Jiangkou plant has passed EU EMA audits. LianheAigen has passed the TGA audit and received the Notification of Results of Pharmaceutical Suitability Survey issued by PMDA in 2024. In the meanwhile, LianheAigen holds a number of certificates for exporting APIs to the European Union. 4. Outstanding comprehensive management and SHEQ&C governance The Company has built a mature and complete international comprehensive management system, integrating the management of safe production, quality and standard control, environmental protection, R&D and confidentiality, supply chain management business line, key account and project. This has laid a solid management foundation for the comprehensive internationalization of the company. In addition, the company has 9 major chemical production sites for distributed production capacity layout and flexible backup, and officially commenced the construction of our Malaysian site in 2024, thereby mitigating the impact of potential "black swan" events in any single region on supply capacity.
Full description
Lianhe Chemical Technology Co. Limited (hereinafter referred to as ‘the Company’) is a leading chemical and technology solutions provider serving the fields of crop protection, pharmaceuticals, performance chemicals and equipment and engineering services. It is committed to achieving the strategic vision of becoming a world-leading solution provider in chemistry and technology. To improve core competitiveness, the strategy of ‘focus, foresight and alliance’ is being implemented. In the field of crop protection, the Company, as a trailblazer and leader in crop protection contract manufacturing in China, is always adhering to the principle of customer-orientation, and closely following the trends of the customer demand and the industry over the past 30 years of development. Thanks to its comprehensive advantage in technological innovation, production management, quality management and logistics management capabilities, the Company has proactively carried out strategic cooperation with our key customers abroad, expanded and deepened the partnership, and continuously provided innovative services. The Company has established long-term and close strategic cooperative relations with many international giants in chemical process research and development, engineering amplification technology and industrial production of products. As a result, the Company acquired an important place in global supply systems of key customers, becoming a preferred partner for major agrochemical clients. In the field of pharmaceuticals, after years of development, the company has established relations with many of the world's top 20 multinational pharmaceutical companies and carried out active cooperation, the related business has achieved rapid growth. On this basis, the company strives to develop new strategic customers to further consolidate the foundation for future development. With the increasing expenditure on R&D and innovation of new small and medium-sized pharmaceutical enterprises and the increasing difficulty of production process, the cooperation business between the company and innovative pharmaceutical companies has been growing steadily. In order to better provide integrated services to customers, the company has set up an R&D platform for new technology and established a professional team to actively develop R&D business in the upstream of the industry. At present, this team has completed interface with important customers. The company will develop into more uninvolved fields, including long-chain lipids, etc., to enhance its own research and development capabilities to meet market demand better. In the field of performance chemicals, the Company is currently working with customers in multiple emerging areas such as personal care products, electronic chemicals, battery chemicals, photovoltaic industry and environmentally friendly materials. The Company has developed and supplied a variety of competitive key materials and intermediates by using its own technical expertise and production resources. In the field of the equipment and engineering services, the company provides services for cold-chain logistics, photovoltaic power generation, petrochemical and other industries. The company adheres to independent research and development, in the meanwhile, introduce external technology project, to create a stable and high-quality product line, and form technology and industrial chain scale advantages.